Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · William Blair

William Blair Small Cap Growth Fund Class R6 (WBSRX)

Ticker WBSRX · Since 2019-05-02 · · Holdings as of Jun 30, 2026

Expense ratio
0.94%$94/yr per $10k
5-yr return
+5.0%annualized
1-yr return
+3.1%as of Dec 2025
Net assets
$1.2Ball share classes
Holdings
93

Bottom line

Is WBSRX a good fund? The bottom line

WBSRX is the Class R6 share class of William Blair Small Cap Growth Fund, a managed small-cap mutual fund from William Blair.

It charges 0.94% — about $94 a year on every $10,000 invested, cheaper than 57% of small-cap funds we track.

It returned +3.1% over one year, +5.0% a year over five years (as of Dec 31, 2025, per its prospectus).

With $1.2 billion in net assets and 93 holdings, its largest position is Diebold Nixdorf Inc (2.3%) and the top 10 make up 18.7% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What WBSRX invests in

The William Blair Small Cap Growth Fund seeks long-term capital appreciation.

Under normal market conditions, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in stocks of small capitalized (small cap) companies. The Fund invests primarily in a diversified portfolio of equity securities, including common stocks and other forms of equity investments (e.g., securities convertible into common stocks), of small cap U.S. growth companies that are expected to exhibit quality growth characteristics. The Funds investments in small cap companies may include a significant weighting to micro-cap companies (which, for purposes of the Fund, are companies with market capitalizations of $1 billion or less at the time of the Funds investment). For purposes of the Fund, the Adviser considers a company to be a small cap company if it has a market capitalization no larger than the largest capitalized company included in…

From the fund's prospectus (filed Apr 29, 2026).

WBSRX performance

Average annual total returns
1 yr5 yr10 yr
WBSRX+3.1%+5.0%—
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full WBSRX performance history →

What WBSRX costs

On a $10,000 investment, WBSRX's 0.94% expense ratio costs about $94 a year. The prospectus estimates $1,230 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full WBSRX fee table →

WBSRX top 10 holdings

#Holding% of fund
1Diebold Nixdorf Inc2.29%
2Fixed Income Clearing Corp.1.99%
3Krystal Biotech Inc1.94%
4Veracyte Inc1.89%
5Cognex Corp1.85%
6Alignment Healthcare Inc1.84%
7Flowserve Corp1.73%
8Establishment Labs Holdings Inc1.73%
9Regal Rexnord Corp1.71%
10Vericel Corp1.70%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 18.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to WBSRX

More funds like WBSRX →

WBSRX FAQ

What is the expense ratio of WBSRX?
WBSRX's expense ratio is 0.94%, which works out to about $94 a year for every $10,000 invested. The prospectus estimates total costs of $1,230 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is WBSRX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does WBSRX hold?
WBSRX's largest holdings are Diebold Nixdorf Inc (2.3%), Fixed Income Clearing Corp. (2.0%), Krystal Biotech Inc (1.9%), Veracyte Inc (1.9%), Cognex Corp (1.8%). It holds 93 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is WBSRX's 5-year return?
WBSRX returned +5.0% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does WBSRX have a sales load?
No. WBSRX has no front-end sales charge.
Who manages WBSRX?
WBSRX is offered by William Blair through William Blair Funds.